Controversies
Controversies tied to this brand in public sources. A listing is not a finding of fault.
Back to profile1 entries
2024
FDA issues Class I recall for Abbott HeartMate pumps
Recall announced
The FDA issued its most serious recall for Abbott subsidiary Thoratec's HeartMate II and HeartMate 3 pumps, affecting nearly 14,000 devices. The devices can develop a buildup of biological material that reduces blood-flow capability; the article reports that the recall was linked by the agency to hundreds of injuries and at least 14 deaths.
Company response
Ongoing disclosure — Abbott
In a written response, Abbott said it had communicated the risk to customers this year.
Source excerpt
A pair of heart devices manufactured by a subsidiary of North Chicago-based Abbott Laboratories has received the FDA’s most serious recall after being linked to hundreds of injuries and at least 14 deaths, the agency has announced.
According to the FDA’s recall notice, the devices can cause buildup of “biological material” that reduces their ability to help the heart circulate blood and keep patients alive.
The recall affects nearly 14,000 devices.